CYP4Z1 and breast carcinoma: The authors further confirmed that the ceRNET formed between CYP4Z1 and the pseudogene CYP4Z2P serves as a sub-ceRNET specifically dedicated to hTERT, as it competitively binds to miR-125a-3p, consequently inhibiting apoptosis in breast cancer cells [65].